- NSE
- BETA
- ISIN
- INE351Y01019
BETA DRUGS
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹1,881.60
+₹75.70 (+4.19%)
NSE close ·
BETA DRUGS closed at ₹1,881.60 on 9 Nov 2026, up 4.19% on the day, and is up 12.66% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹1,030.30 to ₹2,668.30.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹2,093 Cr
- Industry P/E
- 35.5
Market cap at the 9 Nov 2026 close. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹127 Cr | ₹16.49 Cr | — | ₹14.78 |
Armor risk check
BETA DRUGS moves about 4× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is BETA DRUGS's share price today?
BETA DRUGS (NSE: BETA) closed at ₹1,881.60 on 9 Nov 2026, up 4.19% from the previous close of ₹1,805.90. It traded between ₹1,820.60 and ₹1,925.90 that day.
What are BETA DRUGS's 52-week high and low?
Over the last 52 weeks BETA DRUGS traded between ₹990.10 and ₹2,807.90, adjusted for splits and bonuses.
What are BETA DRUGS's NSE symbol, BSE code and ISIN?
BETA DRUGS has NSE symbol BETA, ISIN INE351Y01019.
How has BETA DRUGS performed over 1, 3 and 5 years?
BETA DRUGS's share price return: 1Y +12.66%, 3Y +18.71% a year, 5Y +24.86% a year. Dividends are not included.
What is BETA DRUGS's market cap?
BETA DRUGS's market cap is ₹2,093 Cr at the close on 9 Nov 2026.
Which sector is BETA DRUGS in?
BETA DRUGS is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how BETA DRUGS fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app